
Organovo Holdings ONVO
Country |
|
IPO year |
- |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ CAPITAL |
Shares |
2.59 M |
Market Cap[1] |
$ 19.4 M |
EBITDA (LTM) |
$ -13.7 M |
P/E (LTM) |
- |
P/S (LTM) |
168.58 |
EPS (LTM) |
-5.43 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Neogen Corporation
NEOG
|
$ 9.4 | 2.29 % | $ 2.04 B | Nasdaq Global Select Market,SPB | ||
|
Natera
NTRA
|
$ 253.82 | 0.63 % | $ 34.7 B | Nasdaq Global Select Market,SPB | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Celcuity
CELC
|
$ 83.26 | 0.97 % | $ 3.89 B | Nasdaq Global Select Market | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Koninklijke Philips N.V.
PHG
|
$ 26.1 | 2.19 % | $ 24.7 B | NYSE | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Personalis
PSNL
|
$ 11.73 | -1.26 % | $ 1.05 B | Nasdaq Global Select Market | ||
|
Quidel Corporation
QDEL
|
$ 16.5 | -1.02 % | $ 695 M | Nasdaq Global Select Market,SPB | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
Co-Diagnostics
CODX
|
$ 1.51 | 7.09 % | $ 2.01 M | Nasdaq Capital Market | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Neuronetics
STIM
|
$ 1.82 | -2.67 % | $ 120 M | Nasdaq Global Select Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | ||
|
CareDx, Inc
CDNA
|
$ 35.41 | -0.95 % | $ 1.89 B | Nasdaq Global Market,SPB | ||
|
NeoGenomics
NEO
|
$ 15.27 | 13.96 % | $ 1.96 B | Nasdaq Global Select Market,SPB | ||
|
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | ||
|
Soleno Therapeutics
SLNO
|
- | - | $ 2.69 B | Nasdaq Capital Market | ||
|
Waters Corporation
WAT
|
$ 379.48 | -1.15 % | $ 22.6 B | NYSE,SPB | ||
|
Medpace Holdings
MEDP
|
$ 584.93 | 2.44 % | $ 16.9 B | Nasdaq Global Select Market,SPB | ||
|
Quest Diagnostics Incorporated
DGX
|
$ 235.22 | -0.31 % | $ 26.1 B | NYSE,SPB | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
Exagen
XGN
|
$ 4.35 | -2.25 % | $ 93.8 M | Nasdaq Global Market | ||
|
Biomerica
BMRA
|
$ 1.59 | -0.62 % | $ 3.65 M | Nasdaq Capital Market | ||
|
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | ||
|
DarioHealth Corp.
DRIO
|
$ 7.1 | -5.27 % | $ 28.3 M | Nasdaq Capital Market | ||
|
OpGen
OPGN
|
- | -16.95 % | $ 1.54 M | Nasdaq Capital Market | ||
|
Anixa Biosciences
ANIX
|
$ 3.48 | -1.14 % | $ 113 K | Nasdaq Capital Market | ||
|
PerkinElmer
PKI
|
- | -0.91 % | $ 14.7 B | NYSE,SPB | ||
|
DexCom
DXCM
|
$ 75.14 | 0.39 % | $ 29.3 B | Nasdaq Global Select Market,SPB | ||
|
OPKO Health
OPK
|
$ 1.37 | -17.27 % | $ 1.03 B | Nasdaq Global Select Market | ||
|
Psychemedics Corporation
PMD
|
- | -1.84 % | $ 15.3 M | Nasdaq Global Select Market | ||
|
ICON Public Limited Company
ICLR
|
$ 178.18 | -1.14 % | $ 14 B | Nasdaq Global Select Market,SPB | ||
|
Quotient Limited
QTNT
|
- | -11.32 % | $ 1.1 M | Nasdaq Global Select Market | ||
|
T2 Biosystems
TTOO
|
- | -39.35 % | $ 313 K | Nasdaq Global Select Market | ||
|
Renalytix AI plc
RNLX
|
- | 5.66 % | $ 22.7 M | Nasdaq Global Market | ||
|
Syneos Health
SYNH
|
- | - | $ 4.46 B | Nasdaq Global Select Market,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.